Sunday, November 1, 2026

EUR/JPY Bearish Momentum With A 1% Slide In The Last 10 Sessions

ViaNews Editorial Team

February 5, 2024

EUR/JPY Bearish Momentum With A 1% Slide In The Last 10 Sessions

(VIANEWS) - EUR/JPY (EURJPY) has been up by 1.02% for the last 10 sessions. At 16:08 EST on Monday, 5 February, EUR/JPY (EURJPY) is $159.70.

EUR/JPY's yearly highs and lows, it's 14.989% up from its 52-week low and 2.788% down from its 52-week high.

Volatility

EUR/JPY's last week, last month's, and last quarter's current intraday variation average was a negative 0.22%, a positive 0.03%, and a positive 0.43%, respectively.

EUR/JPY's highest amplitude of average volatility was 0.37% (last week), 0.32% (last month), and 0.43% (last quarter), respectively.

News about

  • According to DailyForex on Monday, 5 February, "Within the current market dynamics, it is highly probable that the EUR/USD pair will continue to fluctuate within this particular range. ", "Traders may consider using the EUR/USD pair as an indicator for developments related to the US dollar rather than as a direct reflection of the European economic situation. "
  • Eur/usd dips amid powell’s remarks, high US yields. According to FXStreet on Monday, 5 February, "At the time of writing, the EUR/USD trades at 1.0742 after hitting a high of 1.0785.", "The EUR/USD has fallen below the 100-day moving average (DMA) at 1.0783, diving to a new year-to-date (YTD) low of 1.0725, about to pierce the December 8 low of 1.0723. "
  • Eur/usd languishes near YTD low as traders continue to trim fed rate cut bets. According to FXStreet on Monday, 5 February, "A sustained strength beyond, however, might trigger a short-covering rally and allow the EUR/USD pair to reclaim the 1.0900 round figure. ", "This is seen as another factor dragging the EUR/USD pair lower and supports prospects for deeper losses."
  • Eur/usd to drift higher in the second half of the year – MUFG. According to FXStreet on Monday, 5 February, "We remain neutral on EUR/USD in H1 but see a slowing US economy emerging, contrasting somewhat with a modest pick-up in Eurozone growth which will allow for EUR/USD to drift higher in H2, although the move will be curtailed by US political risks."
  • Eur/usd forex signal: bearish price channel - 05 February 2024. According to DailyForex on Monday, 5 February, "My previous EUR/USD signal on 24thJanuarywas not triggered as there was insufficiently bearish price action when the resistance levels were first reached that day.", "In my previous analysis ofthe EUR/USD currency pairalmost two weeks ago, I wrote that the resistance level at $1.0876 looked likely to be the level which would determine what would happen over the day. "

More news about EUR/JPY (EURJPY).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com